Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 3—March 2005

Research

Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes

Nigel J. Temperton*Comments to Author , Paul K. Chan†, Graham Simmons‡, Maria C. Zambon§, Richard S. Tedder*, Yasuhiro Takeuchi*, and Robin A. Weiss*
Author affiliations: *University College London, London, United Kingdom; †Prince of Wales Hospital, Shatin, New Territories, Hong Kong Special Administrative Region, People’s Republic of China; ‡University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA; §Health Protection Agency Central Public Health Laboratory, London, United Kingdom

Main Article

Figure 4

Neutralizing antibodies to severe acute respiratory syndrome–associated coronavirus spike protein in sequential blood samples from 4 representative patients. Lines represent profiles of individual patients. Filled black symbols represent geometric mean titers at individual time points. IC90, 90% inhibitory concentration.

Figure 4. . Neutralizing antibodies to severe acute respiratory syndrome–associated coronavirus spike protein in sequential blood samples from 4 representative patients. Lines represent profiles of individual patients. Filled black symbols represent geometric mean titers at individual time points. IC90, 90% inhibitory concentration.

Main Article

TOP